Abstract
The presence of putative tumor-suppressor genes on chromosome 16q23.2-24.1 has been suggested by LOH analysis in several cancer types. This region overlaps with the fragile site FRA16D and the region of homozygous deletions found in several cancer types. The candidate gene WWOX/FOR has been mapped within this region. The mouse homologue of the WWOX protein has been defined as an apoptogenic protein and an essential partner of p53 in cell death, supporting WWOX as a tumor suppressor gene candidate. We performed an expression study of the WWOX/FOR gene in a series of human breast tumors and breast cancer cell lines, and detected reduced expression of the WWOX/FOR transcript in a series of breast cancer cells. Furthermore, identification of two distinct alternative WWOX transcripts expressed at high levels in human tumors suggests an involvement of the WWOX gene in breast cancer progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- LOH:
-
loss of heterozygosity
- PAC:
-
P1-derived artificial chromosome
- EST:
-
expressed sequence tag
- ADH:
-
alcohol dehydrogenase
References
Aldaz CM, Chen T, Sahin A, Cunningham J, Bondy M . 1995 Cancer Res. 55: 3976–3981
Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA, Aldaz CM . 2000 Cancer Res. 60: 2140–2145
Bieche I, Lidereau R . 1995 Genes Chromosomes Cancer 14: 227–251
Bieche I, Lidereau R . 1999 Cancer Res. 59: 2546–2550
Chang NS, Pratt N, Heath J, Schultz L, Sleve D, Carey GB, Zevotek N . 2001 J. Biol. Chem. 276: 3361–3370
Chesi M, Bergsagel PL, Shonukan OO, Martelli ML, Brents LA, Chen T, Schrock E, Ried T, Kuehl WM . 1998 Blood 91: 4457–4463
Chomczynski P, Sacchi N . 1987 Anal Biochem. 162: 156–159
Cleton-Jansen AM, Moerland EW, Kuipers-Dijkshoorn NJ, Callen DF, Sutherland GR, Hansen B, Devilee P, Cornelisse C . 1994 Genes Chromosomes Cancer 9: 101–107
Davidson JM, Gorringe KL, Chin SF, Orsetti B, Besret C, Courtay-Cahen C, Roberts I, Theillet C, Caldas C, Edwards PA . 2000 Br. J. Cancer 83: 1309–1317
Deng G, Chen L, Schott D, Thor A, Bhargava V, Ljung B, Chew K, Smith H . 1994 Cancer Res. 54: 499–505
Dorion-Bonnet F, Mautalenn S, Hostein I, Longy M . 1995 Genes Chromosomes Cancer 14: 171–181
Driouch K, Briffod M, Champeme MH, Lidereau R . 1998 Cancer Res. 58: 2081–2086
Driouch K, Dorion-Bonnet F, Briffod M, Champeme MH, Longy M, Lidereau R . 1997 Genes Chromosomes Cancer 19: 185–191
Elo JP, Harkonen P, Kyllonen AP, Lukkarinen O, Poutanen M, Vihko R, Vihko P . 1997 Cancer Res. 57: 3356–3359
Frengen E, Zhao B, Howe S, Weichenhan D, Osoegawa K, Gjernes E, Jessee J, Prydz H, Huxley C, de Jong PJ . 2000 Genomics 68: 118–126
Grundy RG, Pritchard J, Scambler P, Cowell JK . 1998 Br. J. Cancer 78: 1181–1187
Ioannou PA, Amemiya CT, Garnes J, Kroisel PM, Shizuya H, Chen C, Batzer MA, de Jong PJ . 1994 Nat. Genet. 6: 84–89
Krummel KA, Roberts LR, Kawakami M, Glover TW, Smith DI . 2000 Genomics 69: 37–46
Larsen F, Gundersen G, Prydz H . 1992 Genet. Anal. Tech. Appl. 9: 80–85
Larsson C, Byström C, Skoog L, Rotstein S, Nordenskjöld M . 1990 Genes Chromosomes Cancer 2: 191–197
Latif F, Fivash M, Glenn G, Tory K, Orcutt ML, Hampsch K, Delisio J, Lerman M, Cowan J, Beckett M, Weichselbaum R . 1992 Cancer Res. 52: 1451–1456
Latil A, Cussenot O, Fournier G, Driouch K, Lidereau R . 1997 Cancer Res. 57: 1058–1062
Li C, Berx G, Larsson C, Auer G, Aspenblad U, Pan Y, Sundelin B, Ekman P, Nordenskjold M, van Roy F, Bergerheim USR . 1999 Genes Chromosomes Cancer 24: 175–182
Lindblom A, Rotstein S, Stoog L, Nordenskjöld M, Larson C . 1993 Cancer Res. 53: 3707–3711
Mangelsdorf M, Ried K, Woollatt E, Dayan S, Eyre H, Finnis M, Hobson L, Nancarrow J, Venter D, Baker E, Richards RI . 2000 Cancer Res. 60: 1683–1689
Mashimo T, Watabe M, Cuthbert AP, Newbold RF, Rinker-Schaeffer CW, Helfer E, Watabe K . 1998 Cancer Res. 58: 4572–4576
Osoegawa K, Mammoser AG, Wu C, Frengen E, Zeng C, Catanese JJ, de Jong PJ . 2001 Genome Res. 11: 483–496
Paige AJ, Taylor KJ, Stewart A, Sgouros JG, Gabra H, Sellar GC, Smyth JF, Porteous DJ, Watson JE . 2000 Cancer Res. 60: 1690–1697
Paige AJ, Taylor KJ, Taylor C, Hillier SG, Farrington S, Scott D, Porteous DJ, Smyth JF, Gabra H, Watson JE . 2001 Proc. Natl. Acad. Sci. USA 98: 11417–11422
Ried K, Finnis M, Hobson L, Mangelsdorf M, Dayan S, Nancarrow JK, Woollatt E, Kremmidiotis G, Gardner A, Venter D, Baker E, Richards RI . 2000 Hum. Mol. Genet. 9: 1651–1663
Sato T, Akiyama F, Satamoko G, Kasumi F, Nakamura Y . 1991 Cancer Res. 51: 5794–5799
Shen Y, Kozman HM, Thompson A, Phillips HA, Holman K, Nancarrow J, Lane S, Chen LZ, Apostolou S, Doggett NA, Callen DF, Mulley JC, Sutherland GR, Richards RI . 1994 Genomics 22: 68–76
Skirnisdottir S, Eiriksdottir G, Baldursson T, Barkardottir RB, Egilsson V, Ingvarsson S . 1995 Int. J. Cancer 64: 112–116
Suzuki H, Komiya A, Emi M, Kuramochi H, Shiraishi T, Yatani R, Shimazaki J . 1996 Genes Chromosomes Cancer 17: 225–233
Takita K, Sato T, Miyagi M, Watatani M, Akiyama F, Sakamoto G, Kasumi F, Abe R, Nakamura Y . 1992 Cancer Res. 52: 3914–3917
Tsuda H, Callen DF, Fukutomi T, Nakamura Y, Hirohashi S . 1994 Cancer Res. 54: 513–517
Tsuda H, Zhang WD, Shimosato Y, Yokota J, Terada M, Sugimura T, Miyamura T, Hirohashi S . 1990 Proc. Natl. Acad. Sci. USA 87: 6791–6794
Watson JE, Gabra H, Taylor KJ, Rabiasz GJ, Morrison H, Perry P, Smyth JF, Porteous DJ . 1999 Genome Res. 9: 226–233
Acknowledgements
We are indebted to the medical and surgical departments of the Centre René Huguenin for their cooperation, and to J Solheim and H Harstad for excellent technical assistance. This work was supported by the Ligue Nationale de Lutte Contre le Cancer (LNCC); the Association pour la Recherche sur le Cancer (ARC), the Research Council of Norway and the Norwegian Cancer Society (EF and HP). K Driouch was supported by a grant from the Ligue Nationale de Lutte Contre le Cancer.
The sequence data described in this paper have been submitted to the GenBank data library under accession numbers AW874683-AW874700, AZ124367-AZ124379, AZ124382.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Driouch, K., Prydz, H., Monese, R. et al. Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors. Oncogene 21, 1832–1840 (2002). https://doi.org/10.1038/sj.onc.1205273
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205273
Keywords
This article is cited by
-
VOPP1 promotes breast tumorigenesis by interacting with the tumor suppressor WWOX
BMC Biology (2018)
-
PARTICLE triplexes cluster in the tumor suppressor WWOX and may extend throughout the human genome
Scientific Reports (2017)
-
Genetic alterations of the WWOX gene in breast cancer
Medical Oncology (2012)
-
Molecular analysis of WWOX expression correlation with proliferation and apoptosis in glioblastoma multiforme
Journal of Neuro-Oncology (2011)
-
Alpha T-catenin (CTNNA3): a gene in the hand is worth two in the nest
Cellular and Molecular Life Sciences (2011)